Michelle joined Pharmaceutical Technology in 2007. She previously served as editor-in-chief of Drug Discovery & Development, G&P, and BioPerform. She has served as the senior science editor for Harvard Medical School followed by almost a decade as the associate editor (life sciences) for American Scientist magazine. In addition, she was formerly a member of the news staff at Science magazine and an editor at Cell. During her business career, she has been a member of the launch teams of two biotech startups, Quantum Genomics (functional genomics) and Karyogen (drug discovery). Michelle also analyzed new ventures at BD Technologies (part of Becton Dickinson) as a member of the business development group. She was trained in molecular biology at Brown and Harvard and holds an MBA from the University of North Carolina at Chapel Hill, where she specialized in corporate finance and entrepreneurship.